Geode Capital Management LLC raised its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE – Free Report) by 1.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,647,979 shares of the company’s stock after purchasing an additional 25,820 shares during the quarter. Geode Capital Management LLC owned 2.47% of Global Medical REIT worth $12,724,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. Commonwealth Equity Services LLC lifted its holdings in shares of Global Medical REIT by 16.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 12,646 shares of the company’s stock valued at $98,000 after acquiring an additional 1,819 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Global Medical REIT by 58.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,260 shares of the company’s stock valued at $48,000 after purchasing an additional 2,301 shares during the last quarter. Rhumbline Advisers raised its holdings in Global Medical REIT by 2.6% during the 4th quarter. Rhumbline Advisers now owns 108,862 shares of the company’s stock valued at $840,000 after buying an additional 2,731 shares during the period. New York State Common Retirement Fund lifted its position in Global Medical REIT by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 94,158 shares of the company’s stock worth $727,000 after buying an additional 2,900 shares during the last quarter. Finally, SG Americas Securities LLC lifted its position in Global Medical REIT by 13.8% in the fourth quarter. SG Americas Securities LLC now owns 25,828 shares of the company’s stock worth $199,000 after buying an additional 3,128 shares during the last quarter. 57.52% of the stock is owned by hedge funds and other institutional investors.
Global Medical REIT Price Performance
Shares of GMRE stock opened at $7.48 on Tuesday. The stock has a 50 day moving average price of $8.25 and a 200 day moving average price of $8.39. Global Medical REIT Inc. has a 52-week low of $6.75 and a 52-week high of $10.46. The company has a debt-to-equity ratio of 1.26, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a market capitalization of $500.20 million, a P/E ratio of -373.81, a P/E/G ratio of 1.43 and a beta of 1.12.
Global Medical REIT Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st were paid a $0.21 dividend. The ex-dividend date was Friday, March 21st. This represents a $0.84 dividend on an annualized basis and a yield of 11.23%. Global Medical REIT’s dividend payout ratio is currently 8,400.00%.
Analyst Ratings Changes
Separately, B. Riley began coverage on shares of Global Medical REIT in a research note on Thursday, April 3rd. They issued a “neutral” rating and a $9.00 target price on the stock.
View Our Latest Report on GMRE
Global Medical REIT Profile
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Recommended Stories
- Five stocks we like better than Global Medical REIT
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- How to Short a Stock in 5 Easy Steps
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.